Patents by Inventor Jason W. Flora

Jason W. Flora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250082004
    Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco.
    Type: Application
    Filed: November 25, 2024
    Publication date: March 13, 2025
    Applicant: Philip Morris USA Inc.
    Inventors: Gerd KOBAL, Justin HEYNEKAMP, Timothy B. LANGSTON, Peter REEH, Munmaya K. MISHRA, Jason W. FLORA
  • Publication number: 20250034518
    Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.
    Type: Application
    Filed: October 14, 2024
    Publication date: January 30, 2025
    Applicant: Philip Morris USA Inc.
    Inventors: Alec J. HAYES, Maria SHULLEETA, Jason W. FLORA
  • Patent number: 12161145
    Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco.
    Type: Grant
    Filed: August 26, 2021
    Date of Patent: December 10, 2024
    Assignee: Philip Morris USA Inc.
    Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
  • Patent number: 12116591
    Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.
    Type: Grant
    Filed: July 5, 2023
    Date of Patent: October 15, 2024
    Assignee: Philip Morris USA Inc.
    Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora
  • Publication number: 20230348849
    Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.
    Type: Application
    Filed: July 5, 2023
    Publication date: November 2, 2023
    Applicant: Philip Morris USA Inc.
    Inventors: Alec J. HAYES, Maria SHULLEETA, Jason W. FLORA
  • Patent number: 11739292
    Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: August 29, 2023
    Assignee: Philip Morris USA Inc.
    Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora
  • Publication number: 20220282209
    Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 8, 2022
    Applicant: Philip Morris USA Inc.
    Inventors: Alec J. HAYES, Maria SHULLEETA, Jason W. FLORA
  • Publication number: 20210378281
    Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco.
    Type: Application
    Filed: August 26, 2021
    Publication date: December 9, 2021
    Applicant: Philip Morris USA Inc.
    Inventors: Gerd KOBAL, Justin HEYNEKAMP, Timothy B. LANGSTON, Peter REEH, Munmaya K. MISHRA, Jason W. FLORA
  • Patent number: 11129405
    Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: September 28, 2021
    Assignee: Philip Morris USA Inc.
    Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
  • Patent number: 10280396
    Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: May 7, 2019
    Assignee: Philip Morris USA Inc.
    Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora
  • Publication number: 20190069595
    Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.
    Type: Application
    Filed: November 2, 2018
    Publication date: March 7, 2019
    Applicant: Philip Morris USA Inc.
    Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
  • Patent number: 10117453
    Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: November 6, 2018
    Assignee: Philip Morris USA Inc.
    Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
  • Publication number: 20180105794
    Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.
    Type: Application
    Filed: December 12, 2017
    Publication date: April 19, 2018
    Applicant: Philip Morris USA Inc.
    Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora
  • Patent number: 9862923
    Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: January 9, 2018
    Assignees: Philip Morris USA Inc., Philip Morris Products S.A.
    Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora
  • Publication number: 20150250227
    Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.
    Type: Application
    Filed: May 22, 2015
    Publication date: September 10, 2015
    Applicant: PHILIP MORRIS USA INC.
    Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
  • Patent number: 9038643
    Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.
    Type: Grant
    Filed: November 7, 2011
    Date of Patent: May 26, 2015
    Assignee: Philip Morris USA Inc.
    Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora, Tatjana Kichko
  • Publication number: 20120247492
    Abstract: An orally-enjoyable tobacco product includes a portion of smokeless tobacco comprising an active ingredient and either: (1) a collection of tobacco particles at least partially enclosed by a coating comprising a water-soluble non-crosslinked component and a substantially water-insoluble cross-linked component, or (2) a pouch comprising smokeless tobacco enclosed in a water-permeable wrapper. The active ingredient is selected from the group consisting of a mercaptan, camphor, borneol, isoborneol, bornyl acetate, isobornyl acetate, mono-bornyl succinate, mono-isobornyl succinate, mono-bornyl formate, and mono-isobornyl formate. The active ingredient is present in an amount effective to reduce or eliminate the sensory irritation arising from the smokeless tobacco. Also disclosed is a method of making such a product.
    Type: Application
    Filed: November 7, 2011
    Publication date: October 4, 2012
    Applicant: Philip Morris USA Inc.
    Inventors: Gerd Kobal, Justin Heynekamp, Timothy B. Langston, Peter Reeh, Munmaya K. Mishra, Jason W. Flora
  • Publication number: 20120042889
    Abstract: Various embodiments are directed to consumable products incorporating a matrix of cultured tobacco cells. Any tobacco variety may be utilized for establishing in vitro tobacco cultures, including native tobacco varieties and genetically modified tobacco varieties derived from any tobacco variety. Various embodiments are directed to methods for producing tobacco products incorporating cellular material and/or extracts derived from tobacco cells cultured in vitro.
    Type: Application
    Filed: March 25, 2011
    Publication date: February 23, 2012
    Applicant: Philip Morris USA Inc.
    Inventors: Alec J. Hayes, Maria Shulleeta, Jason W. Flora